Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: Psychobiological correlates

Journal of Substance Abuse

Volumn 13, Issue 4, 2001, Pages 471-491

  Gerra, Gilberto ^a   Zaimovic, Amir ^a   Ampollini, Roberta ^a   Giusti, Francesca ^a   Delsignore, Roberto ^b   Raggi, Maria Augusta ^c   Laviola, Gianni ^d   Macchia, Teodora ^d   Brambilla, Francesca ^a  

^a AUSL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

3,4 Methylenedioxy methamphetamine; Adrenocorticotropic hormone; Aggressiveness; Cortisol; Ecstasy; Epinephrine; Norepinephrine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ADRENALIN; CATECHOLAMINE; CORTICOTROPIN; HYDROCORTISONE; NORADRENALIN; PSYCHEDELIC AGENT;

ADRENAL FUNCTION; ADULT; AGGRESSION; AGGRESSIVENESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; DRUG ABUSE; DRUG DEPENDENCE; HEART RATE; HISTORY OF MEDICINE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTERVIEW; IRRITABILITY; MEDICAL ASSESSMENT; MONEY; PRIORITY JOURNAL; PSYCHOBIOLOGY; RATING SCALE; REINFORCEMENT; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD; MALE; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; TIME;

ADOLESCENT; ADULT; AGGRESSION; ANALYSIS OF VARIANCE; CORTICOTROPIN; EPINEPHRINE; HALLUCINOGENS; HUMAN; HYDROCORTISONE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NOREPINEPHRINE; PERSONALITY TESTS; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS;

EID: 0035237698     PISSN: 08993289     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3289(01)00094-3     Document Type: Article

References (60)

1. Allen T.J., Moeller F.G., Rhoades H.M., Cherek D.R. Subjects with a history of drug dependence are more aggressive than subjects with no drug use history. Drug and Alcohol Dependence. 46:1997;95-103.
2. Bellomo, R. D. (1995). Aspetti di polizia scientifica. In Atti del Seminario (Ed.), Studi sui Derivati Amfetaminici (pp. 43-48). Italian Ministry of Interior, Rome, Italy.
3. Boyer P. Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatrica Scandinavica, Supplementum. 406:2000;24-29.
4. Brown G.L., Ebert M.H., Goyer P.F., Jimerson D.C., Klein W.J., Bunney W.E., Goodwin F.K. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. American Journal of Psychiatry. 139:1982;741-746.
5. Buss A.H., Durkee A. An inventory for assessing different kinds of hostility. Journal of Consulting Psychology. 21:1957;343-349.
6. Castrogiovanni P., Maremmani I., Di Muro A. Aggressive behaviour and hostility in depression: clinical aspects. Placidi G.F., Dell'Osso L., Nisticò G., Akiskal H.S. Recurrent mood disorders. 1993;51-65 Springer-Verlag, Berlin.
7. Cherek D.R. Effects of smoking different doses of nicotine on human aggressive behavior. Psychopharmacology (Berlin). 75:1981;339-345.
8. Cherek D.R. Point Subtraction Aggression Paradigm (PSAP). 1992;University of Texas, Houston, TX.
9. Coccaro E.F. Central serotonin and impulsive aggression. British Journal of Psychiatry, Supplement. 8:1989;52-62.
10. Darke S., Sims J., McDonald S., Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 95:2000;687-695.
11. Fava M., Guaraldi G.B., Mazzi F., Rigatelli M. Intervista Clinica Strutturata per il DSM-III-R. 1993;Organizzazioni Speciali, Florence.
12. Gamma A., Frei E., Lehmann D., Pascual-Marqui R.D., Hell D., Vollenweider F.X. Mood state and brain electric activity in Ecstasy users. NeuroReport. 11:2000;157-162.
13. Gerra G., Zaimovic A., Avanzini P., Chittolini B., Giucastro G., Caccavari R., Palladino M., Maestri D., Monica C., Delsignore R., Brambilla F. Neurotransmitter-neuroendocrine responses to experimentally induced aggression in humans: influence of personality variable. Psychiatry Research. 66:1997;33-43.
14. Gerra G., Zaimovic A., Chittolini B., Giucastro G., Folli F., Maestri D., Tessoni A., Avanzini P., Caccavari R., Bernasconi S., Brambilla F. Neurotransmitter-hormonal responses to psychological stress in peripubertal subjects: relationship to aggressive behavior. Life Sciences. 62:1998;617-625.
15. Gerra, G., Zaimovic, A., Raggi, M. A., Giusti, F., Delsignore, R., Bertacca, S., & Brambilla, F. (in press). Aggressive responding of male heroin addicts under methadone treatment: psychometric and neuroendocrine correlates. Drug and Alcohol Dependence.
16. Gerra G., Zaimovic A., Rizzi O., Timpano M., Zambelli U., Ventimiglia C. Substance abuse among high-school students: relationship with social coping and temperament. Bulletin on Narcotics. LI(1-2):1999;75-96.
17. Gerra G., Zaimovic A., Zambelli U., Timpano M., Neri E., Marzocchi G.F., Delsignore R., Brambilla F. Long-lasting effects of ±3,4- methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans. Biological Psychiatry. 47:2000;127-136.
18. Giovambattista A., Chisari A.N., Spinedi E. Participation of the central serotonergic pathway in the endotoxin-stimulated hypothalamo-pituitary-adrenal axis function. Medicina (Buenos Aires). 57:1997;441-444.
19. Grob C.S., Poland R.E., Chang L., Ernst T. Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behavioural Brain Research. 73:1996;103-117.
20. Kellam S.G., Stevenson D.L., Rubin B.R. How specific are the early predictors of teenage drug use? NIDA Research Monograph Series. 43:1982;329-334.
21. Kelly T.H., Cherek D.R. The effects of alcohol on free-operant aggressive behavior. Journal of Studies of Alcohol, Supplement. 11:1993;40-52.
22. King J.A., Barkley R.A., Barrett S. Attention-deficit hyperactivity disorder and the stress response. Biological Psychiatry. 44:1998;72-74.
23. Kingery P.M., Pruitt B.E., Hurley R.S. Violence and illegal drug use among adolescents: evidence from the U.S. National Adolescent Student Health Survey. International Journal of Addiction. 27:1992;1445-1464.
24. Kirschbaum C., Pirke K.M., Hellhammer D.H. The "Trier Social Stress Test" - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 28:1993;76-81.
25. Kish S.J., Furukawa Y., Ang L., Vorce S.P., Kalasinsky K.S. Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user. Neurology. 55:2000;294-296.
26. Kofoed L., MacMillan J. Alcoholism and antisocial personality. The sociobiology of an addiction. Journal of Nervous and Mental Diseases. 174:1986;332-335.
27. Leonard B.E. Evidence for a biochemical lesion in depression. Journal of Clinical Psychiatry. 61(Suppl. 6):2000;12-17.
28. Mas M., Farre M., de la Torre R., Roset P.N., Ortuno J., Segura J., Cami J. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. Journal of Pharmacology and Experimental Therapeutics. 290:1999;136-145.
29. Mayerhofer A., Bartke A., Began T. Catecholamines stimulate testicular steroidogenesis in vitro in the Siberian hamster, Phodopus sungorus. Biology of Reproduction. 48:1993;883-888.
30. McCann U.D., Eligulashvili V., Mertl M., Murphy D.L., Ricaurte G.A. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4 methylenedioxymethamphetamine (MDMA) users. Psychopharmacology (Berlin). 147:1999;56-65.
31. McCann U.D., Ridenour A., Shaham Y., Ricaurte G.A. Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology. 10:1994;129-138.
32. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet. 352:1998;1433-1437.
33. Miller L. Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style. Journal of Substance Abuse and Treatment. 8:1991;277-291.
34. Moeller F.G., Dougherty D.M., Rustin T., Swann A.C., Allen T.J., Shah N., Cherek D.R. Antisocial personality disorder and aggression in recently abstinent cocaine dependent subjects. Drug and Alcohol Dependence. 44:1997;175-182.
35. Morgan M.J. Lasting psychological sequelae of recreational use of MDMA (Ecstasy): controlled studies in humans. Journal of Psychopharmacology. 12:1998;101-102.
36. Morgan M.J. Recreational use of "Ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology. 19:1998;252-264.
37. Muntaner C., Walter D., Nagoshi C., Fishbein D., Haertzen C.A., Jaffe J.H. Self-report vs. laboratory measures of aggression as predictors of substance abuse. Drug and Alcohol Dependence. 25:1990;1-11.
38. Navarro J.F., Maldonado E. Behavioral profile of quinpirole in agonistic encounters between male mice. Methods and Finding in Experimental and Clinical Pharmacology. 21:1999;477-480.
39. Netter P., Henning J., Roed I.S. Serotonin and dopamine as mediators of sensation seeking behavior. Neuropsychobiology. 34:1996;155-165.
40. Parrott A.C., Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berlin). 139(3):1998, October;261-268.
41. Parrott A.C., Sisk E., Turner J.J. Psychobiological problems in heavy 'Ecstasy' (MDMA) polydrug users. Drug and Alcohol Dependence. 60(1):2000, July 1;105-110.
42. Pfohl B., Blum N., Zimmerman M., Stangl D. Structured Interview for Personality Disorders, revised version. 1989;University of Iowa, Iowa City, IA.
43. Raggi M.A., Sabbioni C., Casamenti G., Gerra G., Calonghi N., Masotti L. Determination of catecholamines in human plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography, B: Biomedical Sciences and Applications. 730:1999;201-211.
44. Rao U., Ryan N.D., Dahl R.E., Birmaher B., Rao R., Williamson D.E., Perel J.M. Factors associated with the development of substance use disorder in depressed adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 38:1999;1109-1117.
45. Ricaurte G.A., McCann U.D., Szabo Z., Scheffel U. Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Toxicology Letters. 112-113:2000;143-146.
46. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 39:2001;32-41.
47. Rothman R.B., Partilla J.S., Baumann M.H., Dersch C.M., Carroll F.I., Rice K.C. Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. Synapse. 35:2000;222-227.
48. Schifano F., Di-Furia L., Forza G., Minicuci N., Bricolo R. MDMA (Ecstasy) consumption in the context of polydrug abuse: a report on 150 patients. Drug and Alcohol Dependence. 52:1998;85-90.
49. Specka M., Finkbeiner T., Lodemann E., Leifert K., Kluwig J., Gastpar M. Cognitive-motor performance of methadone-maintained patients. European Addiction Research. 6:2000;8-19.
50. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured Clinical Interview according to DSM-III-R. 1990;American Psychiatric Press, Washington, DC.
51. Stabeneau J.R. Family pedigree studies of biological vulnerability to drug dependence. NIDA Research Monograph Series. 89:1988;25-40.
52. Tarter R.E., Blackson R., Brigham J., Moss H., Caprara G.V. The association between childhood irritability and liability to substance use in early adolescence: a 2-year follow-up study of boys at risk for substance abuse. Drug and Alcohol Dependence. 39:1995;253-261.
53. Tuchtenhagen F., Daumann J., Norra C., Gobbele R., Becker S., Pelz S., Sass H., Buchner H., Gouzoulis-Mayfrank E. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent Ecstasy (MDMA) users. Neuropsychopharmacology. 22:2000;608-617.
54. Virkkunen M., Linnoila M. Brain serotonin, type II alcoholism and impulsive violence. Journal of Studies of Alcohol, Supplement. 11:1993;163-169.
55. Volpi R., Caffarra P., Boni S., Scaglioni A., Malvezzi L., Saginario A., Chiodera P., Coiro V. ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain. Neuropsychobiology. 35:1997;73-78.
56. Wareing M., Fisk J.E., Murphy P.N. Working memory deficits in current and previous users of MDMA ('Ecstasy'). British Journal of Psychology. 91:2000;181-188.
57. Weinmann W., Bohnert M. Lethal monointoxication by overdosage of MDEA. Forensic Science International. 91:1998;91-101.
58. Wiliams I., Wilson J.D., Foster D.W. Text book of endocrinology. 1985;Saunders, Philadelphia.
59. Wyatt R.J., Portnoy B., Kupfer D.J., Snyder F. Engelman resting plasma catecholamine concentrations in patients with depression and anxiety. Archives of General Psychiatry. 24:1971;65-70.
60. Zuckerman M. Zuckerman M. Behavioral expressions and biosocial bases of sensation seeking. 1994;Cambridge University Press, Cambridge.